Flexion Therapeutics, Inc.
 (FLXN)

- NASDAQ
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Nov. 9, 2015, 4:08 PM
    • Flexion Therapeutics (NASDAQ:FLXN): Q3 EPS of -$0.52 beats by $0.08.
    | Nov. 9, 2015, 4:08 PM
  • Aug. 6, 2015, 4:34 PM
    • Flexion Therapeutics (NASDAQ:FLXN): Q2 EPS of -$0.58 misses by $0.04.
    | Aug. 6, 2015, 4:34 PM
  • May 7, 2015, 4:48 PM
    • Flexion Therapeutics (NASDAQ:FLXN): Q1 EPS of -$0.43 beats by $0.13.
    | May 7, 2015, 4:48 PM
  • Mar. 24, 2015, 6:51 AM
    • Flexion Therapeutics (FLXN -6.4%) FY14 results: Revenues: $0; R&D Expense: $17.9M (+61.3%); SG&A: $9.1M (+35.8%); Operating Loss: ($27M) (-51.7%); Net Loss: ($27.3M) (-50.0%); Loss Per Share: ($1.97) (+91.4%); Quick Assets: $151.6M (+824.4%).
    • No guidance given.
    | Mar. 24, 2015, 6:51 AM
  • Mar. 23, 2015, 4:19 PM
    • Flexion Therapeutics (NASDAQ:FLXN): FY'14 EPS of -$1.97
    • Cash & cash equivalents of $0.1M.
    | Mar. 23, 2015, 4:19 PM
  • Nov. 13, 2014, 4:33 PM
    • Flexion Therapeutics (NASDAQ:FLXN): Q3 EPS of -$0.45 beats by $0.10.
    • Quick Assets of $67.3M.
    | Nov. 13, 2014, 4:33 PM
  • Aug. 8, 2014, 10:39 AM
    • Flexion Therapeutics (FLXN +1.6%) Q2 results: Revenues: $0; Net Loss: ($5.9M) (-29.0%); Loss Per Share: ($0.38) (+93.5%); Quick Assets: $72.0M (+339.0%).
    • No financial guidance given.
    | Aug. 8, 2014, 10:39 AM
  • Aug. 7, 2014, 6:36 PM
    • Flexion Therapeutics (NASDAQ:FLXN): Q2 EPS of -$0.38 beats by $0.14.
    | Aug. 7, 2014, 6:36 PM
Company Description
Flexion Therapeutics Inc is a development stage specialty pharmaceutical company. The Company is engaged in the development and commercialization of novel, long-acting, injectable pain therapies including; anti-inflammatory and analgesic therapies.